May 2, 2013—The Health Resources and Services Administration (HRSA) “is continuing to work” with the White House Office of Management and Budget (OMB) on a final regulation to implement the Affordable Care Act’s (ACA) restriction on 340B discounts for orphan drugs purchased by hospitals that became eligible for 340B under health care reform, a HRSA spokesperson said this morning.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)